Your search returned 3 results.

Results
	1.	Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure. [electronic resource] by Bartha, Eva Kiss, Gyongyi N Kalman, Endre Kulcsár, Gyozo Kálai, Tamás Hideg, Kálmán Habon, Tamas Sumegi, Balazs Toth, Kalman Halmosi, Robert Producer: 20081222 In: Journal of cardiovascular pharmacology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts. [electronic resource] by Pálfi, Anita Tóth, Ambrus Kulcsár, Gyozo Hantó, Katalin Deres, Péter Bartha, Eva Halmosi, Róbert Szabados, Eszter Czopf, László Kálai, Tamás Hideg, Kálmán Sümegi, Balázs Tóth, Kálmán Producer: 20051128 In: The Journal of pharmacology and experimental therapeutics vol. 315 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. [electronic resource] by Palfi, Anita Toth, Ambrus Hanto, Katalin Deres, Peter Szabados, Eszter Szereday, Zoltan Kulcsar, Gyozo Kalai, Tamas Hideg, Kalman Gallyas, Ferenc Sumegi, Balazs Toth, Kalman Halmosi, Robert Producer: 20061027 In: Journal of molecular and cellular cardiology vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)